John Catanzaro
1 min readJan 24, 2019

Cancer Hallmark Analytics

Cancer Cell and Tumor Microenvironment

2019 John A. Catanzaro

Immunocentric innovations require analysis, typing and network integration. Cancer Hallmark Analytics, is a proposed cancer evaluation system that will begin with personal exome profiling, cancer / tumor exome profiling, HLA typing, proteomic mapping, immunogenetic mapping and interrogation of Cancer Hallmark constituents for both cancer cell and tumor microenvironment.

#proteomics #cancer #pattern #immunotherapy #molecular #cancergenomics

John Catanzaro

John A. Catanzaro is CEO of Neo7logix, a bioscience company that designs precision and personalized treatment designs. www.neo7logix.com